Release Date: 24-Apr-2014
Over the past 5 years, the global cell therapy market has witnessed huge investments in research and development activities, which have attracted the interests of many cell therapy industry firms, medical centers and academic institutions. Additionally, there have been many mergers, collaborations, acquisitions and partnerships taking place in the global cell therapy industry in the past 3 years, between the companies developing cell therapy technology. All these developments have led to the positive overall growth of the global cell therapy market.
Applications of cell-based therapies in Central Nervous System, bone and skin continue to expand. Other than these, cancer, neurology and diabetes are the other most popular indications for cell therapies. There are immense growth opportunities in these target therapeutic areas owing to the ever rising incidence of these life-threatening diseases in almost all countries of the world. There is a large unmet need for these diseases, which cell therapies can satisfy to a great extent.
The global market for cell therapy was valued at close to USD 2.5 Billion in 2012. With continuous advances and developments in this field of medicine, the global cell therapy market is expected to grow at a high rate of 20-22% to reach approximately USD 8 Billion by 2018. Several products and technologies of cell-based therapies are in the R&D pipeline which is expected to enter the market during the forecast period, thus resulting in an increased growth rate.
“Global Cell Therapy Market & Pipeline Insight” Report Highlights & Findings:
For More Information Visit: “Global Cell Therapy Market & Pipeline Insight”